Gentle stem-cell transplant hints at rejuvenating aging blood and immunity in mice

A study in mice shows that transplanting young, lab-expanded blood-forming stem cells into aged animals—without chemotherapy or radiation—restores blood production and rebirths of immune cells (naive B and T cells), effectively reshaping the aging immune system. While the approach worked in mice and used a gentler method (including targeted helpers to spare healthy cells), it is far from clinical use in humans and faces safety, regulatory, and scalability hurdles; nonetheless, experts see potential for future therapies that renew the body’s blood-forming system rather than wide-ranging anti-aging cures.